Latest Ratios: P/E Ratio 138.8x · EV/EBITDA 14.9x · ROE 0.6%. (2020–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Market Cap | $6M | $5M | $67M | — | — | — | — |
| Enterprise Value | $11M | $49M | $127M | — | — | — | — |
| P/E Ratio → | 138.78 | 13.91 | 8.25 | — | — | — | — |
| P/S Ratio | 0.33 | 0.03 | 0.28 | — | — | — | — |
| P/B Ratio | 0.81 | 0.08 | 1.18 | — | — | — | — |
| P/FCF | 2.64 | 0.26 | — | — | — | — | — |
| P/OCF | 2.14 | 0.21 | 156.58 | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.35 | 0.54 | — | — | — | — |
| EV / EBITDA | 14.90 | 8.07 | 7.24 | — | — | — | — |
| EV / EBIT | 49.82 | 15.57 | 9.88 | — | — | — | — |
| EV / FCF | — | 2.80 | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 36.9% | 36.9% | 21.0% | 20.1% | 12.0% | 9.4% | 6.4% |
| Operating Margin | 1.3% | 1.3% | 4.9% | 5.2% | 5.4% | 4.0% | -2.0% |
| Net Profit Margin | 0.2% | 0.2% | 3.4% | 2.5% | 3.6% | 2.3% | -1.8% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| ROE | 0.6% | 0.6% | 29.6% | — | — | — | — |
| ROA | 0.3% | 0.3% | 7.1% | 6.7% | 30.2% | 10.5% | -5.2% |
| ROIC | 1.2% | 1.2% | 10.6% | 21.8% | 90.3% | — | — |
| ROCE | 1.9% | 1.9% | 19.8% | 43.5% | — | — | — |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.82 | 0.82 | 1.22 | — | — | — | — |
| Debt / EBITDA | 7.69 | 7.69 | 3.95 | 4.39 | 4.48 | 2.88 | — |
| Net Debt / Equity | — | 0.78 | 1.06 | — | — | — | — |
| Net Debt / EBITDA | 7.31 | 7.31 | 3.43 | 3.92 | 4.03 | 2.73 | — |
| Debt / FCF | — | 2.54 | — | — | — | 2.61 | 10.35 |
| Interest Coverage | 2.32 | 2.32 | 3.43 | 2.00 | 3.51 | 3.89 | -0.11 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 2.61 | 2.61 | 1.84 | 0.91 | 0.40 | 0.34 | 0.40 |
| Quick Ratio | 2.01 | 2.01 | 1.75 | 0.84 | 0.39 | 0.34 | 0.39 |
| Cash Ratio | 0.12 | 0.12 | 0.23 | 0.08 | 0.08 | 0.01 | 0.00 |
| Asset Turnover | — | 1.19 | 1.74 | 1.92 | 8.30 | 5.98 | 2.85 |
| Inventory Turnover | 7.15 | 7.15 | 51.49 | 26.16 | 235.11 | 320.50 | 128.87 |
| Days Sales Outstanding | — | 23.21 | 54.46 | 67.77 | 27.96 | 56.22 | 108.58 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | 4.9% | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | 0.7% | 7.2% | 12.1% | — | — | — | — |
| FCF Yield | 37.9% | 378.2% | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | — | — | — | — |
| Shares Outstanding | — | $508000 | $3M | $3M | $3M | $3M | $2M |
Severe revenue concentration risk
Based on current market data, NCI trades at a P/S ratio of 0.33, which appears to reflect deep investor skepticism regarding the firm's ability to return to historical growth levels following the reported 41.76% revenue contraction observed in recent fiscal periods.
The elevated P/E of 136.56 is largely an artifact of near-zero net income rather than a signal of high growth expectations. Investors should interpret this valuation as a reflection of extreme earnings volatility, where the market is pricing in significant downside risk rather than future expansion potential.
According to recent financial statements, NCI's ROIC has collapsed to -0.3% in 2025Q4, down from 1.4% in 2025Q2, indicating that the company is currently failing to generate returns that exceed its cost of capital while managing its integrated retail and manufacturing asset base.
The decay in ROIC suggests that the capital deployed into the les 100 ciels retail brand is not yielding sufficient incremental returns to offset the cyclical weakness in the wholesale segment. This trend warrants investigation into whether the current asset base is over-capitalized relative to the firm's diminished revenue capacity.
As reported in recent filings, NCI's asset turnover ratio of 0.61 in 2025Q4 highlights a significant decline in the efficiency with which the company utilizes its asset base to generate revenue compared to its historical operational benchmarks.
The rapid shift in DSO from 99 days to 15 days suggests an aggressive, potentially unsustainable effort to liquidate receivables to bolster liquidity. This volatility in working capital cycles implies that the company's operational leverage is highly sensitive to the timing of client payments and inventory turnover.
Based on the 2025Q4 balance sheet, NCI maintains a current ratio of 2.61, yet this figure is heavily influenced by inventory and receivables that may be subject to impairment, leaving the firm with a cash position of only $2.3M against substantial operational overhead.
While the current ratio appears superficially healthy, the underlying quality of current assets is questionable given the recent revenue collapse. Investors should monitor the firm's ability to meet short-term obligations without further liquidating core assets at distressed prices.
The P/B ratio of 0.80 is frequently misapplied to NCI as a signal of value, yet it obscures the reality that a significant portion of the book value is tied to goodwill and PPE that may be subject to future impairment charges.
Using P/B as a valuation floor is dangerous here because the company's equity base is being eroded by accumulated deficits. A more appropriate metric would be an adjusted tangible book value that accounts for the potential obsolescence of retail inventory and the underutilization of manufacturing assets.
Includes 30+ ratios · 6 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying NCI stock.
Neo-Concept International Group Holdings Limited's current P/E ratio is 138.8x. The historical average is 11.1x. This places it at the 100th percentile of its historical range.
Neo-Concept International Group Holdings Limited's current EV/EBITDA is 14.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 7.7x.
Neo-Concept International Group Holdings Limited's return on equity (ROE) is 0.6%. The historical average is 15.1%.
Based on historical data, Neo-Concept International Group Holdings Limited is trading at a P/E of 138.8x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Neo-Concept International Group Holdings Limited has 36.9% gross margin and 1.3% operating margin.
Neo-Concept International Group Holdings Limited's Debt/EBITDA ratio is 7.7x, indicating high leverage. A ratio above 4x may signal elevated financial risk.